Catalyst Pharmaceuticals, Inc. (CPRX) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI

Catalyst Pharmaceuticals, Inc. (CPRX) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI | MarketCI

CPRX

Market Closed

Catalyst Pharmaceuticals, Inc.

NASDAQHealthcare Biotechnology

182 employees

CEO: Richard John Daly

Founded: 2006

$31.49

+$0.00(+NaN%)

Market Cap

3.85B

Beta

0.74

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Financial Statements

Comprehensive breakdown of financial statements and performance metrics

Gross Margin

85.2%

18.6%

CAGR: 43.3%

Profit after direct costs

Operating Margin

43.8%

32.1%

CAGR: 48.9%

Core business profitability

Net Margin

36.4%

30.8%

CAGR: 52.6%

Bottom line profitability

Revenue Growth

19.8%

YoY

CAGR: 43.0%

Top line growth rate

Revenue Flow Analysis

Visual flow showing how CPRX allocates revenue across expenses and profit

Fiscal Year 2025

Revenue Distribution

Flow of revenue through cost categories to net income

Gross Margin

85.2%

$501.74M

Operating Margin

43.8%

$257.78M

Net Margin

36.4%

$214.33M

Detailed Income Statement

Complete profit and loss breakdown with margin analysis and historical comparison

Item	2021	2022	2023	2024	2025	YoY Change
Total Revenue	140.83M	214.20M	398.20M	491.73M	588.99M	19.8%
Cost of Revenue	(21.88M)	(34.39M)	(51.97M)	(68.84M)	(87.25M)	26.7%
Gross Profit	118.95M	179.81M	346.24M	422.89M	501.74M	18.6%
Operating Expenses
Research & Development	(16.94M)	(19.79M)	(93.15M)	(12.65M)	(12.71M)	0.5%
Selling, General & Administrative	(49.63M)	(57.09M)	(133.71M)	(177.74M)	(193.75M)	9.0%
General & Administrative	(23.48M)	(53.78M)	(47.02M)	(167.74M)	(71.51M)	-57.4%
Selling & Marketing	(26.15M)	(3.30M)	(86.69M)	(10.00M)	(122.24M)	1122.4%
Depreciation & Amortization	(192.00K)	(1.24M)	(32.88M)	(37.77M)	(37.87M)	0.3%
Operating Income (EBIT)	52.38M	101.84M	86.81M	195.12M	257.78M	32.1%
Non-Operating Items
Interest Income	—	—	—	16.06M	—	-100.0%
Interest Expense	—	—	—	—	—	—
Other Income/Expenses (Net)	282.00K	2.88M	7.70M	21.14M	25.74M	21.8%
Income Before Tax	52.67M	104.72M	94.51M	216.26M	283.51M	31.1%
Income Tax Expense	(13.19M)	(21.64M)	(23.10M)	(52.37M)	(69.19M)	32.1%
Net Income	39.48M	83.08M	71.41M	163.89M	214.33M	30.8%
Per Share Metrics
Earnings Per Share (Basic)	$0	$1	$1	$1	$2	26.8%
Weighted Avg Shares Outstanding	103.38M	103.37M	106.28M	118.46M	122.29M	3.2%
Weighted Avg Shares Outstanding (Diluted)	107.80M	111.38M	113.75M	124.94M	127.26M	1.9%
EBITDA	52.86M	105.96M	127.39M	254.04M	321.39M	26.5%

Explore CPRX

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

CPRX in the Healthcare

Mid Cap

Healthcare

Browse sector stocks →

Biotechnology

Browse industry stocks →